News & Updates

Antimicrobial resistance (AMR) in ventilator-associated pneumonia and bloodstream infections in Asia is common and associated with high mortality rates and reduced quality of life, as shown in the ACORN-HAI study.

Adjunctive azithromycin use during unscheduled cesarean deliveries has increased following the landmark C/SOAP trial in 2016, resulting in a decrease in postpartum infection rates in a real-world US cohort.

Atypical otopathogens of otitis media (OM) are more commonly detected in older children and correlate with distinct disease phenotypes but similar outcomes to typical pathogens, according to a study.

In individuals with untreated HIV-1 infection, the two-drug dolutegravir/lamivudine (DTG/3TC) antiretroviral therapy (ART) regimen has similar efficacy as the three-drug bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen, according to the phase IIIb VOGUE study.

A 10-year study in Japan has found that the seasonality of Kawasaki Disease (KD) has not returned to the usual winter-dominant pattern even after lifting the COVID-19 infection mitigation measures.

A pharmacist-led provider education results in better prescribing patterns for antimicrobial discharge prescriptions, according to a study.

Advances in antiretroviral therapy (ART) have transformed HIV management, with life expectancy among people living with HIV (PLHIV) now comparable to that of the general population. This makes choosing a durable regimen that can sustain treatment success over the long term increasingly important. Recent real-world evidence highlights the durability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF), an integrase strand transfer inhibitor (INSTI)–based three-drug regimen, in both treatment-naïve and treatment-experienced settings.

Treatment with bulevirtide monotherapy for up to 144 weeks is safe, well tolerated, and effective in patients with chronic hepatitis D (CHD), a study has shown.